In fact, the number of Foxp3+ Tregs in colonic tissue was increased by the administration of Bifico in pretreated-Bifico-colitis and pretreated + treated-Bifico-colitis groups compared with the colitis group (Figure 6(c)). This evidence concerns the gene FOXP3 and colitis.